Roger Song
Stock Analyst at Jefferies
(0.49)
# 3,036
Out of 4,413 analysts
19
Total ratings
23.81%
Success rate
-25.46%
Average return
Main Sectors:
Top Industries:
14 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NUVL Nuvalent | Initiates: Buy | $97 | $70.65 | +37.30% | 1 | Apr 17, 2024 | |
| TRML Tourmaline Bio | Maintains: Buy | $41 → $72 | $15.71 | +358.31% | 2 | Mar 20, 2024 | |
| VKTX Viking Therapeutics | Initiates: Buy | $110 | $76.43 | +43.92% | 1 | Mar 7, 2024 | |
| NKTR Nektar Therapeutics | Maintains: Hold | $0.5 → $1 | $1.65 | -39.39% | 4 | Mar 6, 2024 | |
| IGMS IGM Biosciences | Assumes: Buy | $61 → $55 | $9.48 | +480.17% | 1 | Nov 9, 2022 | |
| ALT Altimmune | Maintains: Buy | $30 → $35 | $7.07 | +395.05% | 1 | Aug 31, 2022 | |
| PRLD Prelude Therapeutics | Initiates: Buy | $9 | $3.73 | +141.29% | 1 | Jul 29, 2022 | |
| CTMX CytomX Therapeutics | Downgrades: Hold | $12 → $2 | $5.13 | -61.01% | 2 | Jul 7, 2022 | |
| KURA Kura Oncology | Initiates: Buy | $35 | $20.28 | +72.58% | 1 | Feb 15, 2022 | |
| AADI Aadi Bioscience | Initiates: Buy | $675 | $1.94 | +34,693.81% | 1 | Jan 11, 2022 | |
| CRVS Corvus Pharmaceuticals | Initiates: Buy | n/a | $1.61 | - | 1 | Dec 1, 2021 | |
| GLYC GlycoMimetics | Upgrades: Buy | n/a | $1.62 | - | 1 | Nov 12, 2021 | |
| MTEM Molecular Templates | Initiates: Buy | n/a | $1.65 | - | 1 | Sep 8, 2020 | |
| STRO Sutro Biopharma | Initiates: Buy | n/a | $3.74 | - | 1 | Sep 2, 2020 |
Nuvalent
Apr 17, 2024
Initiates: Buy
Price Target: $97
Current: $70.65
Upside: +37.30%
Tourmaline Bio
Mar 20, 2024
Maintains: Buy
Price Target: $41 → $72
Current: $15.71
Upside: +358.31%
Viking Therapeutics
Mar 7, 2024
Initiates: Buy
Price Target: $110
Current: $76.43
Upside: +43.92%
Nektar Therapeutics
Mar 6, 2024
Maintains: Hold
Price Target: $0.5 → $1
Current: $1.65
Upside: -39.39%
IGM Biosciences
Nov 9, 2022
Assumes: Buy
Price Target: $61 → $55
Current: $9.48
Upside: +480.17%
Altimmune
Aug 31, 2022
Maintains: Buy
Price Target: $30 → $35
Current: $7.07
Upside: +395.05%
Prelude Therapeutics
Jul 29, 2022
Initiates: Buy
Price Target: $9
Current: $3.73
Upside: +141.29%
CytomX Therapeutics
Jul 7, 2022
Downgrades: Hold
Price Target: $12 → $2
Current: $5.13
Upside: -61.01%
Kura Oncology
Feb 15, 2022
Initiates: Buy
Price Target: $35
Current: $20.28
Upside: +72.58%
Aadi Bioscience
Jan 11, 2022
Initiates: Buy
Price Target: $675
Current: $1.94
Upside: +34,693.81%
Corvus Pharmaceuticals
Dec 1, 2021
Initiates: Buy
Price Target: n/a
Current: $1.61
Upside: -
GlycoMimetics
Nov 12, 2021
Upgrades: Buy
Price Target: n/a
Current: $1.62
Upside: -
Molecular Templates
Sep 8, 2020
Initiates: Buy
Price Target: n/a
Current: $1.65
Upside: -
Sutro Biopharma
Sep 2, 2020
Initiates: Buy
Price Target: n/a
Current: $3.74
Upside: -